Gait instability in valproate-treated patients: Call to measure ammonia levels.

Svetlana KipervasserC E ElgerA D KorczynR D NassC M QuesadaM Y Neufeld

Published in: Acta neurologica Scandinavica (2017)

Gait instability due to hyperammonemia and VPA treatment is probably under-recognized in many patients. It can develop when the VPA levels are within the reference range and with normal or slightly elevated liver enzymes.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
room temperature
combination therapy